Welcome to the InfoSci Platform
Reference Hub4
Open Innovation in R&D: Co-Patenting With Breakthrough Innovations in Pharma

Open Innovation in R&D: Co-Patenting With Breakthrough Innovations in Pharma

Bassem E. Maamari, Alfred Osta
Copyright: © 2022 |Volume: 18 |Issue: 1 |Pages: 11
ISSN: 1548-0666|EISSN: 1548-0658|EISBN13: 9781799893608|DOI: 10.4018/IJKM.296261
Cite Article Cite Article

MLA

Maamari, Bassem E., and Alfred Osta. "Open Innovation in R&D: Co-Patenting With Breakthrough Innovations in Pharma." IJKM vol.18, no.1 2022: pp.1-11. http://doi.org/10.4018/IJKM.296261

APA

Maamari, B. E. & Osta, A. (2022). Open Innovation in R&D: Co-Patenting With Breakthrough Innovations in Pharma. International Journal of Knowledge Management (IJKM), 18(1), 1-11. http://doi.org/10.4018/IJKM.296261

Chicago

Maamari, Bassem E., and Alfred Osta. "Open Innovation in R&D: Co-Patenting With Breakthrough Innovations in Pharma," International Journal of Knowledge Management (IJKM) 18, no.1: 1-11. http://doi.org/10.4018/IJKM.296261

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

Breakthrough innovations are crucial drivers of economic progress, often depending on external knowledge sources to complement internal knowledge. Co-patenting is one way to achieve this by implementing open innovation within research and development. The purpose of this paper is to explore the impact of co-patenting on breakthrough innovations in the pharmaceutical industry. A research question is tested empirically using an archival dataset comprising 866 patents in Pharma. The findings show that co-patenting has a significant positive impact on breakthrough innovations. Short of previous investigation, this paper provides new empirical insights on the open innovation and co-patenting levels, leading to both academic and practical implications on the field.